The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Open accessAbstract
CRISPR reveals that many cancer drug targets are dispensable for cell proliferation and identifies CDK11 as the target of one mischaracterized agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–227 of 227
Alachkar, H., Mutonga, M., Malnassy, G., Park, J.-H., Fulton, N. C., Woods, A., Meng, L., Kline, J. P., Raca, G., Odenike, O. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5418 · Cited by 27
Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines
Li, J., Hu, X. F., Loveland, B. E., & Xing, P. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.08.002 · Cited by 26
Inhibition of Pim–1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells
Jie, W., He, Q., Luo, B., Zheng, S., Kong, Y.-Q., Jiang, H., Li, R., Guo, J., & Shen, Z. (2012) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(12)60132-1 · Cited by 26
Clinical and biological significance of PIM1 kinase in osteosarcoma
Liao, Y., Feng, Y., Shen, J. K., Gao, Y., Cote, G. M., Choy, E., Harmon, D. C., Mankin, H. J., Hornicek, F. J., & Duan, Z. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.23134 · Cited by 26
Ryu, H.-W., Lee, D. H., Shin, D.-H., Kim, S. H., & Kwon, S. H. (2015) · Planta Medica · doi:10.1055/s-0034-1396149 · Cited by 25
Wang, F., Liu, Y., Wang, L., Yang, J., Zhao, Y., Wang, N., Cao, Q., Gong, P., & Wu, C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12566 · Cited by 24
Pai, J., Hsu, C., Hua, K., Yu, S.-Y., Huang, C.-Y., Chen, C.-N., Liao, C., & Weng, M. (2015) · Molecules · doi:10.3390/molecules20058000 · Cited by 24
Valente, S., Trisciuoglio, D., Tardugno, M., Benedetti, R., Labella, D., Secci, D., Mercurio, C., Boggio, R., Tomassi, S., Maro, S. D., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300005 · Cited by 21
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation
Uchida, E., Suwa, S., Yoshimoto, R., Watanabe, K., Kasama, T., Miura, O., & Fukuda, T. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4740 · Cited by 21
Li, N., Tie, X., Liu, P., Zhang, Y., Ren, H., Gao, X., & Xu, Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.685 · Cited by 19
Liu, Y., Lee, H., Lai, M.-J., Pan, S., Huang, H.-L., Kuo, F.-C., Chen, M.-C., & Liou, J. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01509j · Cited by 19
Identification of quinones as novel PIM1 kinase inhibitors
Schroeder, R. L., Goyal, N., Bratton, M. R., Townley, I. K., Pham, N. A., Tram, P., Stone, T., Geathers, J. S., Nguyen, K., & Sridhar, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.079 · Cited by 19
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells
Mawas, A. S., Amatya, V. J., Suzuki, R., Kushitani, K., El-Din, M. M. M., & Takeshima, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3863 · Cited by 19
Fan, R.-F., Lu, Y., Fang, Z., Guo, X., Chen, Y., Xu, Y., Lei, Y.-M., Liu, K.-F., Lin, D.-J., Liu, L., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7215 · Cited by 19
Self-citationZhang, H., Zhang, J., Hao, C., Zhou, Y. Y., Wang, J., Cheng, M., Zhao, D., & Li, F. (2017) · PubMed Central · Cited by 19
Chen, F., Li, R., Wang, C., Cao, L., Wang, Y., & Yu, L. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2964 · Cited by 18
Zarredar, H., Pashapour, S., Farajnia, S., Ansarin, K., Baradaran, B., Ahmadzadeh, V., & Safari, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28357 · Cited by 18
Science, C. D. (2018) · Figshare · doi:10.6084/m9.figshare.6025238 · Cited by 16
Zaman, S., Wang, R., & Gandhi, V. V. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.07.005 · Cited by 15
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
Barrantes, I. D. B., Attolini, C. S., Slobodnyuk, K., Igea, A., Gregorio, S., Gawrzak, S., Gomis, R. R., & Nebreda, Á. R. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.11.021 · Cited by 15
Wang, L., Kofler, M., Brosch, G., Melesina, J., Sippl, W., Martínez, E. D., & Easmon, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134556 · Cited by 14
Song, W.-J., Dong, Y., Luo, C., & Chen, Y. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.08.003 · Cited by 14
PAC-1 and its derivative WF-210 Inhibit Angiogenesis by inhibiting VEGF/VEGFR pathway
Wang, F., Wang, L., Li, Y., Wang, N., Wang, Y., Cao, Q., Gong, P., Yang, J., & Wu, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.035 · Cited by 13
ACY 1215, a histone deacetylase 6 inhibitor, inhibits cancer cell growth in melanoma.
Wang, F., Bw, Z., & Zr, Z. (2018) · PubMed · Cited by 13
DepMap, B. (2018) · Figshare · doi:10.6084/m9.figshare.6931364 · Cited by 13
Li, Q., Zhang, X., Wei, N., Liu, S., Ling, Y., & Wang, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.085 · Cited by 11
Biochemical changes of salivary gland adenoid cystic carcinoma cells induced by SGI-1776
Hou, X., Yu, Y., Feng, J., Wang, J., Zheng, C., Ling, Z., Ge, M., & Zhu, X. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.029 · Cited by 9
Cited by
Oughtred, R., Rust, J., Chang, C., Breitkreutz, B., Stark, C., Willems, A., Boucher, L., Leung, G., Kolas, N., Zhang, F., et al. (2021) · Protein Science · doi:10.1002/pro.3978 · Cited by 1,858
“Conversely, screens that enrich for sgRNA-generated indels that cause resistance to a particular drug, 54 – 56 toxin, 57 pathogen, 58,59 or adverse environmental condition 60 are termed positive selection screens (Figure 3).”
BackgroundWhy 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Zhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab953 · Cited by 665
Metadata
- Authors
- Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., Sausville, E. L., Lukow, D. A., Liu, L., Chait, A. R., Galluzzo, Z. C., Tucker, C., & Sheltzer, J. M.
- Venue
- Science Translational Medicine
- Published
- 2019-09-11
- Volume
- 11
- Issue
- 509
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2973039076
- Cited by
- 754
- References
- 227
- FWCI
- 49.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.